Lobbying

Glucotrack GCTK's latest lobbying report covers Q2 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $60K. Its first report covers Q1 2025; the issues it reports most are Budget/Appropriations and Defense.

GlucotrackGCTK

Glucotrack stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$60K
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q1 2025
The first quarter a report named it

Lobbying by quarter

Glucotrack lobbying by quarter
Glucotrack lobbying by quarter
QuarterAmountReports
Q1 2025$40K1
Q2 2025$50K1
Q3 2025$50K1
Q4 2025$60K1
Q1 2026$01
Q2 2026$01
Q3 2026$00

By issue

  • Budget and appropriations$66.7K · 6 reports
  • Defense$66.7K · 6 reports
  • Health issues$66.7K · 6 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • SENATE6 reports
  • Defense, Dept of (DOD)1 reports

Firms it paid

Firm
McAllister & Quinn$200K6 quarters

Former officials lobbying for it

Former position
ANDREW QUINNSA, LA - Rep. HoyerQ2 2026
BRANDON REALI - Rep. CuellarQ2 2026
ELIZABETH FOLEYLA - Rep. McCollumQ2 2026

Lobbying reports

Filed by
07/21for Q2McAllister & QuinnUnder $5,000
04/21for Q1McAllister & QuinnUnder $5,000
01/20for Q4 2025McAllister & Quinn$60K
25/10/14for Q3 2025McAllister & Quinn$50K
25/07/21for Q2 2025McAllister & Quinn$50K
25/04/21for Q1 2025McAllister & Quinn$40K
25/04/10for Q1 2025McAllister & QuinnUnder $5,000